Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 2, Number 2—April 1996

The Reemergence of Visceral Leishmaniasis in Brazil

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Jorge R. Arias*, Pedro S. Monteiro†, and Fabio Zicker‡
Author affiliations: *Pan American Health Organization, Brasilia, Brazil; †National Visceral Leishmaniasis Control Program, Ministry of Health, Brasilia, Brazil; ‡Pan American Health Organization, Washington, D.C.

Cite This Article

Because of a complex array of factors, an increasing number of new and reemerging infectious diseases are being recognized in both industrialized and developing countries in the Americas (1,2). The expanding population, living in overcrowded conditions with inadequate housing and sanitary facilities, has been exposed to new diseases and human pathogens. For example, the appearance of the South American arenaviruses (Junin, Machupo, and Guanarito) illustrates how exploitation of new areas for human settlement and agriculture increases the likelihood that new infectious diseases will emerge. Cholera, plague, AIDS, dengue hemorrhagic fever, and urban/periurban visceral leishmaniasis are examples of new and reemerging diseases in the region.

In tropical America, zoonotic visceral leishmaniasis caused by Leishmania chagasi, an intracellular protozoon, is a long-lasting infectious disease characterized by weight loss, cough, fever, diarrhea, hepatosplenomegaly, and lethargy. Since not all symptoms appear simultaneously, and many other conditions manifest the same symptoms, the diagnosis is not always opportune. This disease is different from the anthroponotic form of visceral leishmaniasis found in Sudan and India. In the New World this disease is more common among poor, malnourished children (3) under 15 years of age who live in semiarid regions. The case-fatality rate is low if pentavalent antimony therapy is introduced promptly (4). The disease has also been reported in immunodepressed persons, especially those with HIV infection.

The domestic dog is the principal animal reservoir of L. chagasi and, as the constant companion of humans throughout the endemic-disease area, contributes to the dispersal of diseases during human migrations. The protozoon is transmitted from one mammalian host to another, including humans, primarily by the bite of a sand fly who has fed on an infected dog. In the Americas, the principal sand fly vector is Lutzomyia longipalpis (5). This 2- to 3-mm long fly has peridomestic and intradomiciliary habits (6) and avidly bites humans at night, primarily during twilight, while the host is resting.

Visceral leishmaniasis is usually diagnosed by identifying the parasite in spleen aspirates; microscope examination of bone marrow aspirates offers a satisfactory alternative. Specific antibodies may be detected by immune-enzymatic reactions and immunofluorescence, but these methods lack specificity and are too complex to be carried out in the field. TRALd, a recently developed diagnostic test, consists of a 60-second dipstick, based on a recombinant protein rK39 of a sequence of 298 amino acids and an improved serologic procedure (7). The procedure is undergoing field testing and appears to be a promising tool for control programs.

Although visceral leishmaniasis was previously known as a rural disease, large outbreaks and epidemics of visceral leishmaniasis have been reported recently in large cities in Brazil because of the favorable epidemiologic conditions associated with the reduction of the natural ecologic space of this zoonosis. Waves of droughts, lack of available farm land, and famine have led to a large migration of the population, to the peripheral suburbs of large cities, creating densely populated settlements of shanties (favelas) with minimal infrastructure and sanitation. Most families that migrate are young, less-established farmers of peak child-bearing age; children under 15 years of age account for a large percentage of the entire population. In these communities, the newly introduced disease (parasite) encounters a vast number of nonimmune hosts who, because of poor living conditions, are malnourished; malnutrition is one of the prime risk factors for L. chagasi infection and visceral leishmaniasis (3). The habit of keeping domestic animals such as dogs, chickens, and horses in the back yard provides an abundance of blood meals for sand fly vectors and raises vector population densities dramatically.

Figure 1

Thumbnail of Number of cases of visceral leishmaniasis from the state of Pianuí, Brazil, 1971 to 1994.

Figure 1. Number of cases of visceral leishmaniasis from the state of Pianuí, Brazil, 1971 to 1994.

Figure 2

Thumbnail of Number of cases of visceral leishmaniasis from the state of Maranhão, Brazil, 1979 to 1994.

Figure 2. Number of cases of visceral leishmaniasis from the state of Maranhão, Brazil, 1979 to 1994.

Two recent examples of reemerging visceral leishmaniasis in Brazil occurred in the citiesof Teresina (population = 678,000), the capital of Piauí State, and São Luís (population = 918,000), the capital of Maranhão State. In Teresina, which has the best-documented records, an epidemic of visceral leishmaniasis occurred from 1981 to 1985; it was initially limited to rural settings, but later spread to peripheral areas of the city (9) (Figure 1). Spraying with residual insecticide helped bring the disease under control during the subsequent 3 years. Since 1989, visceral leishmaniasis has gradually reemerged; it reached epidemic levels by the end of 1992 and peaked in 1994. In the State of Maranhão, the disease reemerged in 1993, (Figure 2), 10 years after a previous epidemic (1982 to 1986). In both Teresina and São Luís, the epidemics were preceded by prolonged, severe drought. The disease was found predominantly among young people who came from rural areas and lived in periurban, substandard housing and kept domestic animals in their back yards. The two states accounted for approximately 40% to 50% of the number of cases reported in the country during 1993 to 1994 (3,000/year).

Emergency control plans based on rapid diagnosis, complete treatment of human patients, spraying of residual insecticide, ultra-low volume spraying, elimination of infected (seropositive) dogs, and health education were initiated in these two cities in July 1994 (10). The incidence rate dropped markedly from January 1995, as expected, since the incubation period of visceral leishmaniasis is 4 to 6 months (11, 12). The remaining reported cases include those with longer incubation periods, as well as others, because of the lack of complete coverage of the control interventions and reduced sensitivity of the current diagnostic tools.

Technical expertise and effective mechanisms to prevent visceral leishmaniasis epidemics and urban transmission exist, but they require social and political commitment as well as the allocation of funds to provide adequate sanitary and satisfactory housing conditions to the population at risk. Visceral leishmaniasis in the Americas must be addressed before it becomes a serious public health problem. Even though it is a zoonosis, control interventions are available that, when properly used, can eliminate urban transmission and keep disease incidence in rural areas at a very low level.



  1. Pan American Health Organization/World Health Organization. Regional plan for action for combating new, emerging, and reemerging infectious diseases. Resolution CD38/17, August 1995. Pan American Health Organization, Washington, D.C., USA.
  2. World Health Organization. Report of the Second WHO Meeting on Emerging Infectious Diseases. Document WHO/CDS/BVI/95.2. Geneva, Switzerland: World Health Organization, January 1995.
  3. Cerf  BJ, Jones  TC, Badaro  R, Sampaio  D, Carvalho  EM, Rocha  H, Malnutrition as a risk factor for severe visceral leishmaniasis. J Infect Dis. 1987;156:10302.PubMedGoogle Scholar
  4. World Health Organization. Control of the leishmaniases: report of a WHO expert committee. Technical Report Series 793. Geneva, Switzerland: World Health Organization, 1990.
  5. Lainson R, Shaw JJ. Epidemiology and ecology of leishmaniasis in Latin America. Nature 1978;273 (Parasit Suppl):595-600.
  6. Young  DG, Arias  JR. Flebotomos: vectores de leishmaniasis en Las Americas. Pan American Health Organization, 1992: Cuaderno Técnico No. 33. Pan American Health Organization, Washington, D.C., USA.
  7. Reed  SG, Sheffler  WG, Burns  JM Jr, Scott  JM, Orge  MG, Ghalib  HW, An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg. 1990;43:6329.PubMedGoogle Scholar
  8. Wilson  ME. Travel and emergence of infectious diseases. Emerg Infect Dis. 1995;1:3949. DOIPubMedGoogle Scholar
  9. Costa  CHN, Pereira  HF, Araújo  MV. Epidemia de leishmaniose visceral no estado do Piauí, Brasil, 1980-1986. Rev Saúde Públ S Paulo 1990;24:361-72.
  10. Ministerio da Saúde. Controle, diagnóstico e tratamento da leishmaniose visceral (calazar). normas técnicas. Normas Técnicas. 1a. edição, Brasilia, Brazil: Fundação Nacional de Saúde, Brasil, 1994.
  11. Manson-Bahr  PEC, Southgate  BA, Harvey  AEC. Development of kala-azar in man after inoculation with a Leishmania from a Kenya sandfly. BMJ. 1963;I:120810. DOIGoogle Scholar
  12. Kirk  R. Studies in leishmaniasis in Anglo-Egyptian Sudan. Trans R Soc Trop Med Hyg. 1942;35:25770. DOIGoogle Scholar




Cite This Article

DOI: 10.3201/eid0202.960213

Table of Contents – Volume 2, Number 2—April 1996

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.


Page created: December 20, 2010
Page updated: December 20, 2010
Page reviewed: December 20, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.